Matisyahu Shulman
7PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Sep 18, 2025
Thresholds for adjunctive medication usage and probability of initiating injectable naltrexone.Kara E Rudolph, Shodai Inose, Nicholas T Williams
|Jun 08, 2025
Factors associated with receipt of second injection of naltrexone for opioid use disorder: Secondary analysis of 5 clinical trials.Matisyahu Shulman, Mei-Chen Hu, Maria A Sullivan
|Aug 05, 2024
Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients.Rachael K Ross, Edward V Nunes, Mark Olfson
|Oct 19, 2023
Commentary on Foot et al.: Clinical considerations in addressing comorbid stimulant use in opioid use disorder.Matisyahu Shulman, Miranda Greiner, Adam Bisaga
|Mar 07, 2021
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".Matisyahu Shulman, Roger Weiss, John Rotrosen
|May 08, 2019
Buprenorphine Treatment for Opioid Use Disorder: An Overview.Matisyahu Shulman, Jonathan M Wai, Edward V Nunes
Pageof 2
